Clinical trials
Cardiovascular Diseases trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 8 |
| 2019 | 9 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
| Recruiting | 14 |
| Terminated | 13 |
| Active, not recruiting | 12 |
| Unknown status | 7 |
| Enrolling by invitation | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| GlaxoSmithKline | 5 |
| Endotronix, Inc. | 4 |
| Hasselt University | 4 |
| Pfizer | 4 |
| Abbott Medical Devices | 3 |
| AstraZeneca | 3 |
| Boston Scientific Corporation | 3 |
| Universitaire Ziekenhuizen KU Leuven | 3 |
| Bayer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 106 |
| Heart Diseases | 33 |
| Vascular Diseases | 17 |
| Heart Failure | 15 |
| Stroke | 13 |
| Coronary Artery Disease | 12 |
| Myocardial Infarction | 12 |
| Hypertension | 11 |
| Myocardial Ischemia | 10 |
| Heart Valve Diseases | 9 |
Trials
Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.